Corrigendum to “Beneficial immune-regulatory effects of novel strains of Aureobasidium pullulansAFO-202 and N-163 produced beta glucans in Sprague Dawley rats” [Clinical Immunology Communications 1 (2021) 29–34]
Saved in:
| Main Authors: | Nobunao Ikewaki, Kadalraja Raghavan, Vidyasagar Devaprasad Dedeepiya, Suryaprakash Vaddi, Masaru Iwasaki, Rajappa Senthilkumar, Senthilkumar Preethy, Samuel JK Abraham |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Clinical Immunology Communications |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772613424000143 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Randomised trial of Aureobasidium pullulans-produced beta 1,3-1,6-glucans in patients with Duchenne muscular dystrophy: favourable changes in gut microbiota and clinical outcomes indicating their potential in epigenetic manipulation
by: Naoki Yamamoto, et al. -
Enhanced expression of dystrophin, IGF-1, CD44 and MYH3 in plasma and skeletal muscles including diaphragm of mdx mice after oral administration of Neu REFIX beta 1,3-1,6 glucan
by: Senthilkumar Preethy, et al.
Published: (2025-02-01) -
Two unique biological response-modifier glucans beneficially regulating gut microbiota and faecal metabolome in a non-alcoholic steatohepatitis animal model, with potential applications in human health and disease
by: Naoki Yamamoto, et al.
Published: (2022-10-01) -
Molecular diagnosis and source tracing of an infection of Aureobasidium pullulans
by: Dongli Liu, et al.
Published: (2019-12-01) -
Effect of add different carbon and nitrogen source on the pullulan polysaccharide production from fungus Aureobasidium pullulans
by: Mouhammed Basheer Ismaeel, et al.
Published: (2023-02-01)